Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.

Prabhu JS, Korlimarla A, Anupama CE, Alexander A, Raghavan R, Kaul R, Desai K, Rajarajan S, Manjunath S, Correa M, Raman R, Kalamdani A, Prasad M, Patil S, Gopinath KS, Srinath BS, Sridhar TS.

Transl Oncol. 2017 Aug;10(4):699-706. doi: 10.1016/j.tranon.2017.04.011. Epub 2017 Jul 11.

2.

HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.

Desai K, Aiyappa R, Prabhu JS, Nair MG, Lawrence PV, Korlimarla A, Ce A, Alexander A, Kaluve RS, Manjunath S, Correa M, Srinath BS, Patil S, Kalamdani A, Prasad M, Sridhar TS.

Tumour Biol. 2017 Mar;39(3):1010428317695028. doi: 10.1177/1010428317695028.

PMID:
28349782
3.

High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers.

Desai K, Nair MG, Prabhu JS, Vinod A, Korlimarla A, Rajarajan S, Aiyappa R, Kaluve RS, Alexander A, Hari PS, Mukherjee G, Kumar RV, Manjunath S, Correa M, Srinath BS, Patil S, Prasad MS, Gopinath KS, Rao RN, Violette SM, Weinreb PH, Sridhar TS.

Cancer Med. 2016 Aug;5(8):2000-11. doi: 10.1002/cam4.756. Epub 2016 May 17.

4.

Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer.

Korlimarla A, Prabhu JS, Remacle J, Rajarajan S, Raja U, C E A, Srinath BS, Manjunath S, K S G, Correa M, M S N P, Sridhar TS.

PLoS One. 2016 Apr 14;11(4):e0153113. doi: 10.1371/journal.pone.0153113. eCollection 2016.

5.

Biosynthesis of highly monodispersed, spherical gold nanoparticles of size 4-10 nm from spent cultures of Klebsiella pneumoniae.

Srinath BS, Ravishankar Rai V.

3 Biotech. 2015 Oct;5(5):671-676. doi: 10.1007/s13205-014-0265-2. Epub 2014 Nov 13.

6.

A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors.

Prabhu JS, Korlimarla A, Desai K, Alexander A, Raghavan R, Anupama C, Dendukuri N, Manjunath S, Correa M, Raman N, Kalamdani A, Prasad M, Gopinath KS, Srinath BS, Sridhar TS.

J Cancer. 2014 Jan 23;5(2):156-65. doi: 10.7150/jca.7668. eCollection 2014.

7.

The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women.

Prabhu JS, Wahi K, Korlimarla A, Correa M, Manjunath S, Raman N, Srinath BS, Sridhar TS.

Tumour Biol. 2012 Apr;33(2):315-23. doi: 10.1007/s13277-012-0343-1. Epub 2012 Feb 24.

PMID:
22362381
8.

Effects of yoga program on quality of life and affect in early breast cancer patients undergoing adjuvant radiotherapy: a randomized controlled trial.

Vadiraja HS, Rao MR, Nagarathna R, Nagendra HR, Rekha M, Vanitha N, Gopinath KS, Srinath BS, Vishweshwara MS, Madhavi YS, Ajaikumar BS, Bilimagga SR, Rao N.

Complement Ther Med. 2009 Oct-Dec;17(5-6):274-80. doi: 10.1016/j.ctim.2009.06.004. Epub 2009 Oct 28.

PMID:
19942107
9.

Effects of a yoga program on cortisol rhythm and mood states in early breast cancer patients undergoing adjuvant radiotherapy: a randomized controlled trial.

Vadiraja HS, Raghavendra RM, Nagarathna R, Nagendra HR, Rekha M, Vanitha N, Gopinath KS, Srinath BS, Vishweshwara MS, Madhavi YS, Ajaikumar BS, Ramesh BS, Nalini R, Kumar V.

Integr Cancer Ther. 2009 Mar;8(1):37-46. doi: 10.1177/1534735409331456. Epub 2009 Feb 3. Erratum in: Integr Cancer Ther. 2009 Jun;8(2):195.

PMID:
19190034
10.

Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: a randomized controlled trial.

Rao MR, Raghuram N, Nagendra HR, Gopinath KS, Srinath BS, Diwakar RB, Patil S, Bilimagga SR, Rao N, Varambally S.

Complement Ther Med. 2009 Jan;17(1):1-8. doi: 10.1016/j.ctim.2008.05.005. Epub 2008 Oct 14.

PMID:
19114222
11.

Influence of yoga on postoperative outcomes and wound healing in early operable breast cancer patients undergoing surgery.

Rao RM, Nagendra HR, Raghuram N, Vinay C, Chandrashekara S, Gopinath KS, Srinath BS.

Int J Yoga. 2008 Jan;1(1):33-41. doi: 10.4103/0973-6131.36795.

12.

Influence of yoga on mood states, distress, quality of life and immune outcomes in early stage breast cancer patients undergoing surgery.

Rao RM, Nagendra HR, Raghuram N, Vinay C, Chandrashekara S, Gopinath KS, Srinath BS.

Int J Yoga. 2008 Jan;1(1):11-20. doi: 10.4103/0973-6131.36789.

13.

Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients.

Raghavendra RM, Nagarathna R, Nagendra HR, Gopinath KS, Srinath BS, Ravi BD, Patil S, Ramesh BS, Nalini R.

Eur J Cancer Care (Engl). 2007 Nov;16(6):462-74.

PMID:
17944760
14.

Amebic perforation of the colon.

Wig JD, Kaushik SP, Saleem MA, Srinath BS, Datta BN, Talwar BL.

Int Surg. 1982 Oct-Dec;67(4 Suppl):486-7.

PMID:
7183622
15.

Acquired Duane's retraction syndrome following Kronlein's operation.

Sood GC, Srinath BS, Krishnamurthy G.

Eye Ear Nose Throat Mon. 1975 Aug;54(8):308-10. No abstract available.

PMID:
1157894

Supplemental Content

Loading ...
Support Center